Cytological screening for cervical cancer in women of reproductive age group

Swati Mittal, Anagha J. Kamath


Background: Cervical cancer is a malignant neoplasm arising from cells of cervix uteri. It is the second most common cancer among women worldwide, affecting about 16 per 1,00,000 women each year.

Methods: A cross sectional study of 400 women of reproductive age group (21-49 years) attending Lady Goschen Hospital and KMC Hospital, Attavar, Mangalore was conducted, and women were screened for the presence of cervical cancer by Pap smear. The results were analyzed with respect to age distribution, age at marriage, parity, symptoms and per-speculum findings. Pregnant women and women with active infection of the genital tract were excluded from the study population.

Results: The age range was 21 to 49 years. Mean age was 38.14 years. Of the 400 women, 398 were married and majority of these, 237 (59.5%), got married between 21-25 years. Menstrual irregularity was the most common presenting symptom, 150/400 (37.5%). Abnormal per speculum findings were seen in 102/400 (25.5%). 17 of 400 Pap smears were abnormal, of which 1 (0.25%) was AG-FN, 2 ASCUS (0.5%), 3 (0.75%) ASC-H, 1 (0.25%) LSIL, 7 (1.75%) HSIL and 3 (0.75%) SCC. Mean age for cancer cervix patients was 42.33 years.

Conclusions: Pap smear screening, which appears to be the most feasible and affordable mode for control of carcinoma cervix in developing countries like India, should be carried out in all women of reproductive age group.


Carcinoma cervix, CIN (cervical intraepithelial neoplasia), HPV (human papilloma virus)

Full Text:



Armstrong EP. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Managed Care Pharmacy. 2010 Apr;16(3):217-30.

Ferlay J. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, version 2.0, Lyon, France: International Agency for Research on Cancer, 2004.

Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins Basic Pathology. 8th ed. Saunders Elsevier;2007:718-721.

Dillman. edited by Oldham RK, Robert O. Principles of cancer biotherapy. 5th ed. Dordrecht: Springer;2009:149.

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999;189(1):12-9.

Vizcaino AP, Moreno V, Bosch FX, MUNoz N, Barros‐Dios XM, Borras J et al. International trends in incidence of cervical cancer: II. Squamous‐cell carcinoma. Int J Cancer. 2000 May 1;86(3):429-35.

Narod SA, Thompson DW, Jain M, Wall C, Green LM, Miller AB. Dysplasia and the natural history of cervical cancer: early results of the Toronto Cohort Study. Eur J Cancer. 1991;27:1411-6.

Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999;91:252-8.

Boyd JT, Doll R. (1964). A study of the aetiology of carcinoma of the cervix uteri. Br J Cancer. 1964;18(3):419.

Badar F, Anwar N, Meerza F, Sultan F. Cervical carcinoma in a Muslim community. Asian Pacific J Cancer Prevent. 2007;8(1):24.

Bhurgri Y, Nazir K, Shaheen Y, Usman A, Faridi N, Bhurgri H et al. Patho-epidemiology of cancer cervix in Karachi South. Asian Pacific J Cancer Prevent. 2007 Jul 1;8(3):357.

Aswathy S, Quereshi MA, Kurian B, Leelamoni K. Cervical cancer screening: Current knowledge and practice among women in a rural population of Kerala, India. Indian J Med Res. 2012;136(2):205.

Mhaske MS, Jawadekar SJ, Saundale SG, Lakde RN. Study of association of gynaecological morbidities and cervical dysplasia among rural women. Global J Res Anal. 2013;2(2):173-5.

Macgregor JE, Baird D. (1963). Detection of cervical carcinoma in the general population. BMJ. 1963;1(5346):1631.

Wahi PN, Luthra UK, Mali S, Shimkin MB. Prevalence and distribution of cancer of the uterine cervix in Agra District, India. Cancer, 1972;30(3):720-5.

Wasti S, Ahmed W, Jafri A, Khan B, Sohail R, Hassan S. Analysis of cervical smears in a Muslim population. Annal Saudi Med. 2004;24:189-192.

Misra JS, Srivastava S, Singh U, Srivastava AN. Risk-factors and strategies for control of carcinoma cervix in India: Hospital based cytological screening experience of 35 years. Indian J Cancer. 2009;46(2):155.

Mulay K, Swain M, Patra S, Gowrishankar S. A comparative study of cervical smears in an urban Hospital in India and a population-based screening program in Mauritius. Indian J Pathol Microbiol. 2009;52(1):34.